Developer of non-toxic drugs designed to facilitate the treatment of cancer. The company's drugs enhance the efficacy of existing chemotherapy regimens without exposing patients to new toxicities, enabling patients to get advanced therapy and speedy recovery.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Secondary Transaction - Private | 01-Dec-2021 | 00.00 | Completed | Generating Revenue | ||
1. Early Stage VC | 23-Jul-2014 | 00.00 | 00.00 | 000.00 | Completed | Generating Revenue |
Name | Representing | Role | Since |
---|---|---|---|
James Sacchettini Ph.D | Rescue Therapeutics | Co-Founder, Chief Scientific Officer, President & Board Member | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Hao Cui | Angel (individual) | Minority | 000 0000 | 000000 0 | |
UCSF Foundation Investment Company | University | Minority | 000 0000 | 000000 0 |